TARIS Biomedical
Developing powerful and targeted new treatments for the millions of patients suffering from difficult-to-treat bladder diseases.
Employees
Enterprise value
$100—150m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Roman Abramovich(exited)
Flagship Pioneering(exited)
Polaris Partners(exited)
Bristol-Myers Squibb(exited)
Yonghua Capital(exited)
RA Capital Management(exited)
Third Rock Ventures(exited)
Flybridge Capital Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.